SCHEMBL18785113

SCHEMBL18785113

Nc1ncnc2c1ncn2[C@H]1C[C@@H](O)C(COP(=O)(O)O)O1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.81
ENPP1 P22413 3/20 0.76
P2RY1 P47900 2/20 0.76
DNPH1 O43598 1/20 0.70
PRKAB2 O43741 1/20 0.70
TRPM2 O94759 1/20 0.70
LDHA P00338 1/20 0.70
ADRB2 P07550 1/20 0.70
FBP1 P09467 1/20 0.70
SRC P12931 1/20 0.70
ADORA1 P30542 1/20 0.70
P2RY2 P41231 1/20 0.70
PRKAG1 P54619 1/20 0.70
PRKAA2 P54646 1/20 0.70
PDE4D Q08499 1/20 0.70
KCNH2 Q12809 1/20 0.70
PRKAA1 Q13131 1/20 0.70
PDE3A Q14432 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
TAS1R3 Q7RTX0 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20341113 1.00 POLB (0.81) POLBENPP1P2RY1DNPH1PRKAB2
SCHEMBL7882477 1.00 POLB (0.81) POLBENPP1P2RY1DNPH1PRKAB2
SCHEMBL11927745 1.00 POLB (0.81) POLBENPP1P2RY1DNPH1PRKAB2
SCHEMBL4546151 1.00 POLB (0.81) POLBENPP1P2RY1DNPH1PRKAB2
SCHEMBL48174 1.00 POLB (0.81) POLBENPP1P2RY1DNPH1PRKAB2
SCHEMBL543475 1.00 POLB (0.81) POLBENPP1P2RY1DNPH1PRKAB2
Water SCHEMBL112387 0.99 POLB (0.79) POLBENPP1P2RY1DNPH1PRKAB2
Triphosphate SCHEMBL27892354 0.96 POLB (0.81) POLBENPP1P2RY1DNPH1PRKAB2
SCHEMBL24538794 0.93 POLB (0.77) POLBENPP1P2RY1DNPH1PRKAB2
SCHEMBL8742200 0.93 POLB (0.77) POLBENPP1P2RY1DNPH1PRKAB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220401617-A1 ADHESIVE COMPOSITIONS COMPRISING THERAPEUTICS REVBIO INC (US) 2022-12-22 US disclosed
US-20170112948-A1 Inorganic-organic hybrid compound Karlsruher Institut für Technologie (DE) 2017-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170112948-A1 Inorganic-organic hybrid compound SLCO4C1, SLCO2A1, SLCO1A2 POLB 3337/4885ENPP1 2601/4885P2RY1 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.